EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. – IMUC

As a result of this scheme, ImmunoCellular’s share price was artificially inflated. On April 10, 2017, the Securities and Exchange Commission announced enforcement actions against ImmunoCellular, as well as other individuals and entities, for engaging in ...